B111003D |
Paeoniflorin (JP 16th;Assay) |
Natural products |
Albiflorin
Paeoniflorin |
YMC-Triart C18 |
TA12S05-1546WT |
B111219A |
Paeoniflorin in Kampo products (JP 16th;Assay) |
Natural products |
Albiflorin
Paeoniflorin |
YMC-Triart C18 |
TA12S05-1546WT |
Q090925J |
Flavonoids |
Natural products |
Daidzein
Luteolin
Kaempferol
Baicalein |
YMC-Triart C18 |
TA12S05-1503WT |
R170515B |
Fumonisin |
Natural products |
Fumonisin B1
Fumonisin B2
Fumonisin B3 |
YMC-Triart C18 |
TA12S03-15Q1PTP |
Q090928C |
Basic drugs |
Drugs, Metabolites |
Chlorpheniramine
Dextromethorphan
Propyl p-hydroxybenzoate
(Propyl paraben) |
YMC-Triart C18 |
TA12S05-1503WT |
AB191031E |
A commercial anti-itch medication |
Drugs, Metabolites |
4-Isopropyl-3-methylphenol
Lidocaine
Diphenhydramine hydrochloride |
YMC-Triart C18 |
TA12S03-1546PTH |
R161118A |
Paclitaxel (Taxol) |
Drugs, Metabolites |
Paclitaxel
Taxol |
YMC-Triart C18 |
TA12S03-0502WT |
U110519C |
Fexofenadine Hydrochloride Tablets |
Drugs, Metabolites |
Fexofenadine hydrochloride |
YMC-Triart C18 |
TA12S05-1046WT |
F131125A |
Duloxetine and its degradation products |
Drugs, Metabolites |
Amino alcohol (3-Methylamino-1-thiophen-2-yl-propan-1-ol)
Para isomer (4-(3-Methylamino-1-shiophen-2-yl-propyl)-naphthalen-1-ol))
ortho isomer (2-(3-Methylamino-1-thiophen-2-yl-propyl)-naphthalen-1-ol)
Duloxetine hydrochloride
α-Naphthol |
YMC-Triart C18 |
TA12S05-1503WT |
F131125A |
Duloxetine and its degradation products |
Drugs, Metabolites |
Amino alcohol (3-Methylamino-1-thiophen-2-yl-propan-1-ol)
Para isomer (4-(3-Methylamino-1-shiophen-2-yl-propyl)-naphthalen-1-ol))
ortho isomer (2-(3-Methylamino-1-thiophen-2-yl-propyl)-naphthalen-1-ol)
Duloxetine hydrochloride
α-Naphthol |
YMC-Triart C18 |
TA12SP9-0502PT |
J100407A |
Benzodiazepine derivatives (Triazolam,Etizolam) - LC/MS |
Drugs, Metabolites |
Triazolam
Etizolam |
YMC-Triart C18 |
TA12S05-0502WT |
F100621A |
Barbiturates |
Drugs, Metabolites |
Barbital
Phenobarbital
Hexobarbital
Pentobarbital
Secobarbital |
YMC-Triart C18 |
TA12S05-0502WT |
F100621B |
Barbiturates in human serum |
Drugs, Metabolites |
Barbital
Phenobarbital
Hexobarbital
Pentobarbital
Secobarbital |
YMC-Triart C18 |
TA12S05-0502WT |
U110611A |
Risperidone (JP 16th;Related substances) |
Drugs, Metabolites |
Risperidone |
YMC-Triart C18 |
TA12S03-1046WT |
U110604C |
Risperidone Tablets and Fine Granules (JP 16th;Dissolution) |
Drugs, Metabolites |
Risperidone |
YMC-Triart C18 |
TA12S05-1546WT |
U120619B |
Simvastatin (JP 16th; Assay) |
Drugs, Metabolites |
Simvastatin
Lovastatin |
YMC-Triart C18 |
TA12S03-H546WT |
U120622A |
Simvastatin (USP 34th; Assay) |
Drugs, Metabolites |
Simvastatin
Lovastatin |
YMC-Triart C18 |
TA12S03-H546WT |
U120608C |
Simvastatin tablets (JP draft) |
Drugs, Metabolites |
Simvastatin |
YMC-Triart C18 |
TA12S05-2546WT |
U120608B |
Simvastatin tablets (JP draft) |
Drugs, Metabolites |
Simvastatin |
YMC-Triart C18 |
TA12S05-1504WT |
U120605E |
Simvastatin tablets (USP 34th; Assay) |
Drugs, Metabolites |
Simvastatin |
YMC-Triart C18 |
TA12S05-2546WT |